1. Home
  2. ELS vs ICLR Comparison

ELS vs ICLR Comparison

Compare ELS & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ELS

Equity Lifestyle Properties Inc.

N/A

Current Price

$61.10

Market Cap

12.1B

Sector

Real Estate

ML Signal

N/A

Logo ICON plc

ICLR

ICON plc

N/A

Current Price

$195.29

Market Cap

13.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELS
ICLR
Founded
1992
1990
Country
United States
Ireland
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1B
13.1B
IPO Year
1994
2001

Fundamental Metrics

Financial Performance
Metric
ELS
ICLR
Price
$61.10
$195.29
Analyst Decision
Buy
Buy
Analyst Count
19
18
Target Price
$68.26
★ $231.29
AVG Volume (30 Days)
★ 2.0M
1.1M
Earning Date
10-20-2026
10-27-2026
Dividend Yield
★ 3.56%
N/A
EPS Growth
★ 2.55
N/A
EPS
★ 1.50
N/A
Revenue
★ $1,531,382,000.00
N/A
Revenue This Year
$2.50
N/A
Revenue Next Year
$4.47
$4.60
P/E Ratio
$40.66
★ $12.91
Revenue Growth
★ 0.34
N/A
52 Week Low
$57.46
$66.57
52 Week High
$69.00
$219.04

Technical Indicators

Market Signals
Indicator
ELS
ICLR
Relative Strength Index (RSI) 50.90 51.53
Support Level $61.11 $157.92
Resistance Level $63.67 $219.04
Average True Range (ATR) 1.15 7.11
MACD -0.03 -2.33
Stochastic Oscillator 48.47 21.43

Price Performance

Historical Comparison
ELS
ICLR

About ELS Equity Lifestyle Properties Inc.

Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company has a portfolio of 453 properties across the US with a higher concentration in the Sun Belt; 38% of its properties are in Florida, 11% in Arizona, and 10% in California. Equity Lifestyle targets owning properties in attractive retirement destinations. More than 70% of the company's properties are either age-restricted or have an average resident age over 55.

About ICLR ICON plc

Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.

Share on Social Networks: